Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
01/16/2023 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 30k | $12.17 | $365.1k | | 01/16/2023 |
05/26/2022 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 20k | $8.31 | $166.2k | | 05/26/2022 |
05/24/2022 | ICHOR HOLDINGS, LTD. | ICHR | Grant | Ordinary Shares, par value $0.0001 | 5.6k | $0.00 | $0 | | 05/24/2022 |
05/27/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 18k | $35.23 | $634.1k | | 05/27/2021 |
05/11/2021 | ICHOR HOLDINGS, LTD. | ICHR | Grant | Ordinary Shares, par value $0.0001 | 2.5k | $0.00 | $0 | | 05/11/2021 |
08/17/2020 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 30k | $16.50 | $495k | | 08/17/2020 |
05/12/2020 | ICHOR HOLDINGS, LTD. | ICHR | Grant | Ordinary Shares, par value $0.0001 | 6.9k | $0.00 | $0 | | 05/12/2020 |
05/12/2020 | ICHOR HOLDINGS, LTD. | ICHR | Grant | Ordinary Shares, par value $0.0001 | 4.6k | $0.00 | $0 | | 05/12/2020 |
09/11/2019 | LAM RESEARCH CORP | LRCX | Sale | Common Stock | 22.1k | $233.77 | $5.2M | | 09/11/2019 |
09/11/2019 | LAM RESEARCH CORP | LRCX | Exercise | Employee Stock Option (Right to Buy) | 22.1k | $42.61 | $943.4k | | 09/11/2019 |
09/06/2019 | LAM RESEARCH CORP | LRCX | Gift | Common Stock | 3.6k | $0.00 | $0 | | 09/06/2019 |
09/06/2019 | LAM RESEARCH CORP | LRCX | Sale | Common Stock | 5k | $229.08 | $1.1M | | 09/06/2019 |
03/01/2019 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 4.7k | $176.75 | $836.6k | | 03/01/2019 |
03/01/2019 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 1k | $176.75 | $177.5k | | 03/01/2019 |
03/01/2019 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 799 | $176.75 | $141.2k | | 03/01/2019 |
03/01/2019 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 486 | $176.75 | $85.9k | | 03/01/2019 |
03/01/2019 | LAM RESEARCH CORP | LRCX | Grant | Common Stock | 2.2k | $0.00 | $0 | | 03/01/2019 |
03/01/2019 | LAM RESEARCH CORP | LRCX | Grant | Market-based Performance Restricted Stock Unit | 3.7k | $0.00 | $0 | | 03/01/2019 |
03/01/2019 | LAM RESEARCH CORP | LRCX | Grant | Employee Stock Option (Right to Buy) | 5.9k | $176.75 | $1.1M | | 03/01/2019 |
02/11/2019 | LAM RESEARCH CORP | LRCX | Exercise | Market-based Performance Restricted Stock Unit | 10.1k | $0.00 | $0 | | 02/11/2019 |
03/22/2018 | LAM RESEARCH CORP | LRCX | Sale | Common Stock | 10k | $224.28 | $2.2M | | 03/22/2018 |
03/08/2018 | LAM RESEARCH CORP | LRCX | Sale | Common Stock | 1.8k | $212.64 | $390.2k | | 03/08/2018 |
03/01/2018 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 1k | $190.07 | $190.6k | | 03/01/2018 |
03/01/2018 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 798 | $190.07 | $151.7k | | 03/01/2018 |
03/01/2018 | LAM RESEARCH CORP | LRCX | Grant | Common Stock | 2.9k | $0.00 | $0 | | 03/01/2018 |
03/01/2018 | LAM RESEARCH CORP | LRCX | Grant | Market-based Performance Restricted Stock Unit | 3.7k | $0.00 | $0 | | 03/01/2018 |
03/01/2018 | LAM RESEARCH CORP | LRCX | Grant | Employee Stock Option (Right to Buy) | 2.9k | $190.07 | $559.6k | | 03/01/2018 |
02/09/2018 | LAM RESEARCH CORP | LRCX | Exercise | Market-based Performance Restricted Stock Unit | 8.1k | $0.00 | $0 | | 02/09/2018 |
02/09/2018 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 1.1k | $165.87 | $176.8k | | 02/09/2018 |
02/09/2018 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 5.1k | $165.87 | $848.3k | | 02/09/2018 |
02/09/2018 | LAM RESEARCH CORP | LRCX | Exercise | Common Stock | 12.1k | $165.87 | $2M | | 02/09/2018 |
03/01/2017 | LAM RESEARCH CORP | LRCX | Grant | Common Stock | 4.8k | $0.00 | $0 | | 03/01/2017 |
03/01/2017 | LAM RESEARCH CORP | LRCX | Grant | Market-based Performance Restricted Stock Unit | 6k | $0.00 | $0 | | 03/01/2017 |
03/01/2017 | LAM RESEARCH CORP | LRCX | Grant | Employee Stock Option (Right to Buy) | 4.8k | $119.67 | $578.2k | | 03/01/2017 |
03/01/2017 | LAM RESEARCH CORP | LRCX | Payment of Exercise | Common Stock | 1.1k | $119.67 | $126.4k | | 03/01/2017 |
|